Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
| 01-2015 | 10-2014 | 07-2014 | 04-2014 | 01-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,908 | 5,331 | 86 | 416 | 236 |
| Receivables | 40 | 47 | 47 | 34 | 9 |
| Inventories | 186 | 231 | 249 | 387 | 429 |
| TOTAL | $4,209 | $5,763 | $478 | $1,031 | $895 |
| Non-Current Assets | |||||
| PPE Net | 90 | 28 | 36 | 42 | 115 |
| Intangibles | 1,262 | 1,305 | 1,345 | 1,378 | 1,403 |
| TOTAL | $1,352 | $1,333 | $1,381 | $1,420 | $1,518 |
| Total Assets | $5,561 | $7,096 | $1,859 | $2,451 | $2,413 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 510 | 510 | 1,096 | 529 | 629 |
| Accrued Expenses | 199 | 154 | 401 | 105 | 154 |
| Other current liabilities | 108 | 211 | 332 | 522 | 730 |
| TOTAL | $817 | $875 | $1,829 | $1,156 | $1,513 |
| Non-Current Liabilities | |||||
| TOTAL | $11 | $12 | $13 | $N/A | $10 |
| Total Liabilities | $828 | $887 | $1,842 | $1,156 | $1,523 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,821 | 39,788 | 39,781 | 28,974 | 27,158 |
| Common Shares | 402 | 398 | 295 | 286 | 259 |
| Retained earnings | -84,891 | -83,155 | -81,221 | -78,546 | -76,497 |
| TOTAL | $4,733 | $6,209 | $17 | $1,295 | $890 |
| Total Liabilities And Equity | $5,561 | $7,096 | $1,859 | $2,451 | $2,413 |